Published in EMBO J on March 01, 1994
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J (1995) 4.72
A novel nuclear structure containing the survival of motor neurons protein. EMBO J (1996) 4.72
HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J (1994) 4.61
The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol (1998) 4.43
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 3.34
The mechanisms of PML-nuclear body formation. Mol Cell (2006) 3.22
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol (1998) 2.97
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J (1995) 2.93
Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol (1999) 2.87
The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol (1997) 2.83
Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J (1999) 2.79
Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol (1997) 2.70
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer (2010) 2.66
Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol (2000) 2.59
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.54
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A (1997) 2.47
PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A (2004) 2.43
Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J (2000) 2.38
Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl Acad Sci U S A (1995) 2.35
Functional architecture in the cell nucleus. Biochem J (2001) 2.28
Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol (1998) 2.26
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A (1998) 2.21
Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol (1998) 2.21
An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol (1998) 2.20
Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol (2000) 2.11
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol (2001) 2.07
A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J (1998) 2.06
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol (1997) 2.06
Spatial relationship between transcription sites and chromosome territories. J Cell Biol (1999) 1.96
Mutational analysis of p80 coilin indicates a functional interaction between coiled bodies and the nucleolus. J Cell Biol (1995) 1.93
Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol (1995) 1.92
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med (1999) 1.91
Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc Natl Acad Sci U S A (1999) 1.88
Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci U S A (1996) 1.86
RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. Mol Cell Biol (1997) 1.83
Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10. J Virol (1997) 1.81
Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol Cell Biol (2000) 1.77
A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell (1999) 1.76
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J Virol (1997) 1.72
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69
Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol (1998) 1.64
The dynamic organization of the perinucleolar compartment in the cell nucleus. J Cell Biol (1997) 1.64
The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol (1996) 1.61
Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments. J Virol (1997) 1.56
Deconstructing PML-induced premature senescence. EMBO J (2002) 1.56
Rad51 expression and localization in B cells carrying out class switch recombination. Proc Natl Acad Sci U S A (1996) 1.50
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J (2001) 1.47
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol (2000) 1.46
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A (1997) 1.46
Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med (2000) 1.43
The RNA 3' cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. EMBO J (1996) 1.42
The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett (1997) 1.41
Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol (1996) 1.40
In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci U S A (1996) 1.39
The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol (1998) 1.38
The perinucleolar compartment and transcription. J Cell Biol (1998) 1.37
Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci U S A (1997) 1.36
Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies. Mol Cell Biol (2000) 1.36
GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes. EMBO J (1996) 1.32
Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci U S A (1995) 1.30
Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 1.28
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J (1996) 1.27
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol (1999) 1.25
Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol (2006) 1.21
Large-scale isolation of Cajal bodies from HeLa cells. Mol Biol Cell (2002) 1.20
Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J (2000) 1.19
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol (2012) 1.17
Nuclear organization in genome stability: SUMO connections. Cell Res (2011) 1.13
Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol (2000) 1.12
Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling. Mol Cell Biol (1997) 1.12
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol (1996) 1.11
Association of the neuron-specific RNA binding domain-containing protein ELAV with the coiled body in Drosophila neurons. Chromosoma (1997) 1.11
A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. EMBO J (1996) 1.08
Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol (1995) 1.08
Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol (2001) 1.05
Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J Virol (2000) 1.04
Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci U S A (1994) 1.03
Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol (2001) 1.02
Cellular localization, expression, and structure of the nuclear dot protein 52. J Cell Biol (1997) 1.02
Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc Natl Acad Sci U S A (1997) 1.02
Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol (1999) 1.02
Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. J Cell Biol (2002) 0.97
Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies. Mol Biol Cell (1998) 0.96
Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci U S A (1995) 0.95
PML body meets telomere: the beginning of an ALTernate ending? Nucleus (2012) 0.94
A role for cytoplasmic PML in cellular resistance to viral infection. PLoS One (2008) 0.94
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. J Biol Chem (2008) 0.93
Identification and punctate nuclear localization of a novel noncoding RNA, Ks-1, from the honeybee brain. RNA (2002) 0.92
The SUMO protease SENP6 is a direct regulator of PML nuclear bodies. Mol Biol Cell (2010) 0.91
The role of post-translational modifications in fine-tuning BLM helicase function during DNA repair. DNA Repair (Amst) (2014) 0.91
Tissue-specific in vitro transcription from the mouse albumin promoter. Cell (1986) 10.54
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 9.40
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell (1991) 7.16
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell (1992) 7.11
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature (1990) 5.24
Visualization of focal sites of transcription within human nuclei. EMBO J (1993) 5.06
Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. J Cell Biol (1993) 4.84
Acute promyelocytic leukemia. N Engl J Med (1993) 4.63
Imprinting a determined state into the chromatin of Drosophila. Trends Genet (1990) 4.04
Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med (1991) 4.02
Identification of a novel nuclear domain. J Cell Biol (1991) 3.91
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci (1992) 3.91
Mapping replicational sites in the eucaryotic cell nucleus. J Cell Biol (1989) 3.89
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science (1991) 3.57
Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science (1990) 3.34
In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell (1993) 3.13
A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med (1988) 2.98
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell (1993) 2.96
Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene (1991) 2.86
Localization of endoplasmic reticulum in living and glutaraldehyde-fixed cells with fluorescent dyes. Cell (1984) 2.73
Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol (1990) 2.73
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci (1992) 2.51
Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc Natl Acad Sci U S A (1991) 2.48
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J (1993) 2.29
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol (1992) 2.24
Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene. Mol Cell Biol (1988) 2.21
Accurate initiation at RNA polymerase II promoters in extracts from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.10
Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J Virol (1987) 1.96
Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp Cell Res (1992) 1.92
PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood (1993) 1.82
RNA travel: tracks from DNA to cytoplasm. Cell (1993) 1.52
A putative zinc-binding protein on lampbrush chromosome loops. EMBO J (1993) 1.47
LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation. Genes Dev (1993) 1.44
Compartmentalization within the nucleus: discovery of a novel subnuclear region. J Cell Biol (1991) 1.37
Developmental and tissue-specific regulation of a novel transcription factor of the sea urchin. Genes Dev (1989) 1.21
Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol (1987) 1.19
[Examination by electron microscope of the VX2 tumor of the domestic rabbit derived from the Shope papilloma]. Bull Assoc Fr Etud Cancer (1961) 1.17
Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies. Clin Exp Immunol (1991) 1.04
RFP is a DNA binding protein associated with the nuclear matrix. Nucleic Acids Res (1992) 1.03
Retinoic acid receptor alpha in acute promyelocytic leukaemia. Cancer Surv (1992) 0.83
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature (1990) 5.24
Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. J Cell Biol (1993) 4.84
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood (1990) 4.36
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci (1992) 3.91
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J (2000) 3.08
Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol (1997) 2.71
Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene (1995) 2.50
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med (2001) 2.41
Binding of matrix attachment regions to lamin B1. Cell (1992) 2.31
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol (1992) 2.24
Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol (1996) 2.23
The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene (1995) 2.23
Nuclear distribution of transcription factors in relation to sites of transcription and RNA polymerase II. J Cell Sci (1997) 2.21
Intranuclear filaments containing a nuclear pore complex protein. J Cell Biol (1993) 2.11
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood (1995) 2.04
The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res (1992) 1.96
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med (1999) 1.91
Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci U S A (1996) 1.86
PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood (1993) 1.82
The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res (2000) 1.80
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77
Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA. J Mol Biol (1996) 1.76
Intranuclear distribution of poly(A) RNA determined by electron microscope in situ hybridization. Exp Cell Res (1993) 1.68
Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol (1990) 1.66
Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol (1997) 1.65
Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (1991) 1.62
Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med (1999) 1.61
Improved techniques for the preparation of ultrathin frozen sections. J Cell Biol (1971) 1.61
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene (1999) 1.59
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood (1995) 1.58
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci U S A (1994) 1.57
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia (2000) 1.55
Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia (1993) 1.55
Intranuclear distribution of U1 and U2 snRNAs visualized by high resolution in situ hybridization: revelation of a novel compartment containing U1 but not U2 snRNA in HeLa cells. Eur J Cell Biol (1993) 1.54
Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril (1995) 1.53
Simultaneous imaging of Pseudomonas fluorescens WCS365 populations expressing three different autofluorescent proteins in the rhizosphere: new perspectives for studying microbial communities. Mol Plant Microbe Interact (2000) 1.51
Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol (2004) 1.51
Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol (1998) 1.50
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A (1996) 1.47
BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. J Exp Med (2001) 1.47
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood (1993) 1.45
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia (2005) 1.44
Interferon-alpha therapy in bcr-abl-negative myeloproliferative neoplasms. Leukemia (2008) 1.43
Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer (2004) 1.43
PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J Cell Biochem (1996) 1.43
BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol (1995) 1.42
The RNA 3' cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. EMBO J (1996) 1.42
Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization. J Virol (2001) 1.41
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia (2006) 1.40
PML/RAR alpha rearrangement in acute promyelocytic leukaemia with t(1;17) elucidated using fluorescence in situ hybridization. Br J Haematol (1997) 1.40
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40
Synthesis and maturation of viral transcripts in herpes simplex virus type 1 infected HeLa cells: the role of interchromatin granules. Gene Expr (1995) 1.38
Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. Br J Cancer (2009) 1.37
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37
Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol (1995) 1.36
Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera. J Immunol (1988) 1.34
Nuclear domains and the nuclear matrix. Int Rev Cytol (1995) 1.33
Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer (1997) 1.33
Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS (1998) 1.32
Isolation and characterization of an equine foamy virus. J Virol (2000) 1.30
Prolyl 4-hydroxylase activity in relation to the oxidation state of enzyme-bound iron. The role of ascorbate in peptidyl proline hydroxylation. Biochim Biophys Acta (1982) 1.30
Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma (1986) 1.30
Physical mapping and nucleotide sequence of a herpes simplex virus type 1 gene required for capsid assembly. J Virol (1989) 1.29
Coiled bodies and U2 snRNA genes adjacent to coiled bodies are enriched in factors required for snRNA transcription. Mol Biol Cell (1998) 1.29
Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci (1995) 1.26
LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood (1996) 1.26
Expression of Drosophila lamin C is developmentally regulated: analogies with vertebrate A-type lamins. J Cell Sci (1995) 1.26
Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am J Pathol (1981) 1.24
Immunocytochemical identification of nuclear structures containing snRNPs in isolated rat liver cells. J Ultrastruct Res (1984) 1.23
Ultrastructure of the nucleus in relation to transcription and splicing: roles of perichromatin fibrils and interchromatin granules. Exp Cell Res (1996) 1.22
Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol (1999) 1.22
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts. Br J Cancer (2009) 1.20
Isolation and characterization of anti-rotavirus immunoglobulins secreted by cloned hybridoma cell lines. J Gen Virol (1983) 1.20
Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood (1999) 1.18
Kaposi's sarcoma and new herpesvirus. Lancet (1995) 1.18
Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol (1991) 1.16
SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis. Oncogene (2000) 1.15
Spatial organization of four hnRNP proteins in relation to sites of transcription, to nuclear speckles, and to each other in interphase nuclei and nuclear matrices of HeLa cells. Exp Cell Res (1999) 1.14
Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet (2010) 1.14
Mitochondrial assembly in yeast. FEBS Lett (1999) 1.13
A new crosslinker for mass spectrometric analysis of the quaternary structure of protein complexes. J Am Soc Mass Spectrom (2001) 1.13
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer (1996) 1.13
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13
Nuclear neighbours: the spatial and functional organization of genes and nuclear domains. J Cell Biochem (1998) 1.12
A recombinant autoantigen derived from the human (U1) small nuclear RNP-specific 68-kd protein. Expression in Escherichia coli and serodiagnostic application. Arthritis Rheum (1988) 1.12
The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J Biol Chem (1990) 1.11
hnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J Cell Biochem (1996) 1.10
Binding of matrix attachment regions to nuclear lamin is mediated by the rod domain and depends on the lamin polymerization state. FEBS Lett (1996) 1.10
All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol (2001) 1.09
Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood (2001) 1.08